SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysisVictor Razuk, Roxana Mehran, Mauro Chiarito et al.|European Heart Journal - Cardiovascular Pharmacotherapy|2022Cited by 41
Efficacy and safety of P2Y12 inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysisJohny Nicolas, Roxana Mehran, Birgit Vogel et al.|European Heart Journal - Cardiovascular Pharmacotherapy|2022Cited by 21
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarctionJohny Nicolas, Roxana Mehran, Frans Beerkens et al.|Journal of Thrombosis and Thrombolysis|2021Cited by 20
Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graftFrans Beerkens, Annapoorna Kini, Ranbir Singh et al.|Catheterization and Cardiovascular Interventions|2021Cited by 5
IMPACT OF CORONARY ARTERY DISEASE ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIALDaniel Feldman, George Dangas, Davide Cao et al.|Journal of the American College of Cardiology|2022Cited by 2